Ant Group’s Profit Plunged 91% as AI and Healthcare Spending Started Hitting China’s Fintech Earnings

Ant Group’s Profit Plunged 91% as AI and Healthcare Spending Started Hitting China’s Fintech Earnings

Ant Group’s quarterly profit fell about 91% to roughly 1.2 billion yuan for the quarter ended Sept. 30, 2025, according to Reuters and Bloomberg calculations based on Alibaba’s latest earnings disclosure, which showed only 393 million yuan in profit contribution from the affiliate. The timing matters beyond one weak quarter. Bloomberg said heavier spending on AI and healthcare, together with declines in the fair value of some investments, helped drive the slump, making Ant one of the clearest early examples of how China’s AI race is starting to create real earnings pressure outside the cloud giants.

The number matters because it came through Alibaba’s earnings

The core profit figure did not arrive through a full standalone Ant Group earnings release. It came through Alibaba Group’s March 19 quarterly results, which disclosed that Ant contributed only 393 million yuan in profit to Alibaba under the equity-accounting line. Reuters and Bloomberg then used Alibaba’s roughly one-third stake to estimate Ant’s own quarterly net profit at around 1.2 billion yuan. That distinction is important because it keeps the story accurate: the 91% plunge is a widely cited market calculation based on Alibaba’s official filing, not a separately published full Ant income statement.

The reporting window also needs to be read carefully. The disclosure happened on March 19, 2026, but the quarter in question ended on Sept. 30, 2025. In other words, the market is reacting now to a lagged earnings snapshot. Even so, the shock value is obvious. For a company that still sits at the center of China’s fintech ecosystem through Alipay and related services, a drop to roughly 1.2 billion yuan is not a routine fluctuation. It is a clear sign that the cost of pursuing new growth areas is starting to hit the bottom line hard enough to break through into the global business press.

Ant is paying for a new growth narrative

Bloomberg’s explanation is what makes this story bigger than an ordinary fintech earnings miss. The report said Ant’s profit was hit by heavier spending on AI and healthcare, along with declines in the fair value of some investments. That matters because it shows the pressure is not coming from only one bad mark-to-market quarter or one temporary operating issue. It is coming from a strategic choice to keep spending on the next phase of growth while carrying the accounting pain that comes with it.

That strategic angle becomes clearer when placed next to Bloomberg’s Feb. 10 report on Ant’s push into AI health. That earlier piece framed Ant as betting on a Chinese online healthcare market worth about 480 billion yuan in 2025, or roughly $69 billion, and described AI health as one of the company’s most important new opportunity pools. We have also already seen how Chinese healthcare AI stories can move from narrative to product evidence, as in our earlier analysis on Alibaba DAMO’s MAOSS using routine CT to more than triple high-risk fatty-liver detection. Put differently, Ant is not being punished for making a random speculative AI move. It is spending against a very large China-specific market thesis: that AI-driven healthcare and digital services can become one of the company’s next meaningful growth engines after payments and traditional fintech matured.

The problem is that markets tend to feel the bill before they see the payoff. AI build-outs, sector-specific model deployment, product integration and healthcare expansion all absorb money up front, while revenue and profit often arrive later and less cleanly. For a company like Ant, that creates a difficult transition period. It is trying to look like more than a payments giant while investors and analysts are still measuring it against the cash-generating profile of its earlier business.

This does not look like a one-quarter accident

One reason the current profit plunge matters is that it does not appear to be isolated. Reuters reported on Aug. 29, 2025, that Ant’s profit in an earlier quarter had already fallen 60.5% year over year, with new growth projects, technology spending and fair-value changes all part of the explanation. That makes the current 91% decline more than a single-quarter anomaly. It suggests Ant has already been living through a period in which investment in new businesses and technology has repeatedly collided with near-term profitability.

That longer arc is what gives the new number its analytical value. If the prior quarter already showed significant profit compression, then the latest result looks less like a sudden collapse and more like an intensification of an existing pattern. The takeaway is not that Ant has lost the capacity to generate profit altogether. It is that the company is in a phase where investment intensity and valuation noise can overwhelm the earnings profile that once made it look like one of China’s most obvious platform winners.

This is also why the contrast with Ant’s broader recent history is useful. Background reporting cited in the source brief said Ant’s full-year 2024 profit was about 38.3 billion yuan, up 61% year over year. Against that backdrop, the new quarter looks even more dramatic. It shows how fast the earnings picture can swing when a company moves from harvesting an existing business to funding a more uncertain AI- and healthcare-oriented future.

The split inside China’s AI economy is getting clearer

The Ant story is especially useful because it shows the other side of a China AI narrative that recently looked more optimistic for infrastructure players. In our recent analysis on Alibaba and Baidu raising AI cloud prices by up to 34%, China’s infrastructure layer was starting to recover pricing power as demand and hardware costs climbed. Ant points in the opposite direction. Instead of monetizing the AI boom through higher prices, it is absorbing the cost of trying to build the next application-layer opportunity. One side of China’s AI market is testing pricing power. Another side is living through earnings pain.

That split matters beyond Ant itself. If one of China’s best-known fintech and platform companies has to accept a 91% quarterly profit decline while investing in AI and healthcare, smaller internet groups, fintech firms and consumer platforms may face even tougher trade-offs. They can keep funding AI expansion and accept thinner margins for longer, or they can protect near-term earnings and risk falling behind in the next platform cycle. Either path is expensive. That is the deeper significance of the Ant result: China’s AI race is no longer only about demand, excitement and model launches. It is also about who can survive the payback gap.

What changed, and what could happen next

What changed in this reporting cycle is that China’s AI story became easier to read through a profit-and-loss statement rather than only through product launches or investment headlines. Ant’s estimated 1.2 billion yuan quarterly profit and 91% year-over-year drop gave the market a hard number showing that AI-related ambition can already be painful for a major Chinese fintech company. Just as important, the reporting did not frame the drop as an AI-only story. It tied the result to both heavier AI and healthcare investment and to fair-value losses, which is exactly the kind of mixed picture investors face when growth bets meet weaker market conditions.

What could happen next is a longer and more uncomfortable ROI conversation across China’s application layer. Cloud providers may still benefit from stronger demand and selective pricing power, but fintech and consumer-platform companies building AI products may need to tolerate multiple quarters of pressure before revenue catches up. Ant will not be the last company forced to make that trade-off. The company’s latest earnings shock changed the frame of the debate: the next phase of China’s AI race will not be judged only by who invests the most or launches the fastest, but by who can keep funding new bets without letting earnings damage become the dominant story.


Sources

  1. Reuters — Ant Group quarterly profit down 91% to 1.2 billion yuan (2026-03-19)
  2. Bloomberg — Jack Ma-Backed Ant’s Profit Fell 91% on AI Spending, Fair Value (2026-03-19)
  3. Alibaba Group — Alibaba Group Announces December Quarter 2025 Results (2026-03-19)
  4. Bloomberg — Jack Ma-Backed Ant Bets on AI Health in $69 Billion Sector Race (2026-02-10)
  5. Reuters — Ant Group quarterly profit falls 60% to $663 million (2025-08-29)

More From Author

OpenClaw Mania Goes Mainstream in China as Schoolkids and Retirees Join the AI-Agent Rush

OpenClaw Mania Goes Mainstream in China as Schoolkids and Retirees Join the AI-Agent Rush

Xiaomi Tied an $8.7 Billion AI Pledge to Its Refreshed SU7 Launch as China’s EV War Turned Into an AI Capex Race

Xiaomi Tied an $8.7 Billion AI Pledge to Its Refreshed SU7 Launch as China’s EV War Turned Into an AI Capex Race

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注